MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
Key Financials
Revenue
$185.7M
↓ 28.3%
Net Income
$-130773000
↑ 9.7%
Operating Income
$-215266000
↑ 8.6%
Gross Profit
$34.0M
↓ 68.6%
EPS (Diluted)
$-0.90
↑ 14.3%
Total Liabilities
$397.9M
↓ 7.7%
Total Assets
$770.6M
↓ 23.6%
Cash & Equivalents
$216.9M
↓ 32.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 8/13/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 10-Q | 8/7/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 4 | 8/3/2026 | View on SEC |
| 4 | 7/10/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
| SCHEDULE 13G | 6/29/2026 | View on SEC |
| SCHEDULE 13G | 6/23/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MRVI |
| Company Name | MARAVAI LIFESCIENCES HOLDINGS, INC. |
| CIK | 1823239 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (858) 546-0004 |